Advertisement
U.S. markets closed

Health Care Select Sector SPDR Fund (XLV)

NYSEArca - NYSEArca Delayed Price. Currency in USD
144.82-0.02 (-0.01%)
At close: 04:00PM EDT
144.53 -0.29 (-0.20%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close144.84
Open145.43
Bid144.60 x 1100
Ask145.10 x 1000
Day's Range144.72 - 145.57
52 Week Range122.59 - 148.27
Volume6,382,778
Avg. Volume8,203,618
Net Assets40.66B
NAV145.40
PE Ratio (TTM)24.54
Yield1.50%
YTD Daily Total Return7.01%
Beta (5Y Monthly)0.69
Expense Ratio (net)0.09%
Inception Date1998-12-16
  • Yahoo Finance Video

    'Continued innovation' is key when investing in weight loss trend

    GLP-1 weight-loss drugs' popularity has paved the way for broadening use cases for people seeking a healthier lifestyle; the Food and Drug Administration (FDA) approved Novo Nordisk's (NVO) Wegouvy to use in treating and decreasing overweight patients' elevated cardiac risks. Tema ETFs Chief Investment Officer Yuri Khodjamirian highlights the pharmaceutical trend's ability to mainstream weight-loss treatments and ways to invest in the healthcare space. Khodjamirian's firm manages its own Tema Cardiovascular and Metabolic ETF (HRTS) "It is extremely important that you're selective. The first thing, you need to have a precise exposure of the theme. you want to make sure the companies that are under the hood in the ETFs are the companies that are going to be winning the way forward in terms of forward-looking winners rather than backward-looking winners," Khodjamirian says. "A lot of times you see in ETFs you have the historic winners rather than future ones." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.

  • Yahoo Finance

    Daily record highs across the S&P 500 are telling investors this rally is broadening

    Despite the "Magnificent Seven" — or three — powering the S&P 500, the long list of companies hitting new record highs shows another side of the market concentration conversation.

  • Yahoo Finance Video

    Stocks have been volatile: Here's what has been working

    Stocks, so far, are higher for the month of February. But it has been a wild ride, with earnings reports and inflation data causing a lot of volatility. Yahoo Finance's Jared Blikre take a closer look at some of the areas if the market that have been performing well despite the whipsaw market action. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.